These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 24064012

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
    Hamzaoui K, Kaabachi W, Fazaa B, Zakraoui L, Mili-Boussen I, Haj-Sassi F.
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease.
    Ahmadi M, Yousefi M, Abbaspour-Aghdam S, Dolati S, Aghebati-Maleki L, Eghbal-Fard S, Khabbazi A, Rostamzadeh D, Alipour S, Shabani M, Nouri M, Babaloo Z.
    J Cell Physiol; 2019 Apr; 234(4):3985-3994. PubMed ID: 30317557
    [Abstract] [Full Text] [Related]

  • 5. Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.
    Chi W, Zhu X, Yang P, Liu X, Lin X, Zhou H, Huang X, Kijlstra A.
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3058-64. PubMed ID: 18579762
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Skewed TGFβ/Smad signalling pathway in T cells in patients with Behçet's disease.
    Shimizu J, Izumi T, Arimitsu N, Fujiwara N, Ueda Y, Wakisaka S, Yoshikawa H, Kaneko F, Suzuki T, Takai K, Suzuki N.
    Clin Exp Rheumatol; 2012 Jul; 30(3 Suppl 72):S35-9. PubMed ID: 22935165
    [Abstract] [Full Text] [Related]

  • 8. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
    Deniz R, Tulunay-Virlan A, Ture Ozdemir F, Unal AU, Ozen G, Alibaz-Oner F, Aydin-Tatli I, Mumcu G, Ergun T, Direskeneli H.
    Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interleukin-28A promotes IFN-γ production by peripheral blood mononuclear cells from patients with Behçet's disease.
    Li B, Xie C, Lin X, Su SB.
    Cell Immunol; 2014 Jul; 290(1):116-9. PubMed ID: 24973639
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Decreased interleukin 27 expression is associated with active uveitis in Behçet's disease.
    Wang C, Tian Y, Ye Z, Kijlstra A, Zhou Y, Yang P.
    Arthritis Res Ther; 2014 May 28; 16(3):R117. PubMed ID: 24887071
    [Abstract] [Full Text] [Related]

  • 13. IL-18 mRNA expression and IFN-gamma induction in bronchoalveolar lavage from Behçet's disease.
    Hamzaoui A, Ghraïri H, Ammar J, Zekri S, Guemira F, Hamzaoui K.
    Clin Exp Rheumatol; 2003 May 28; 21(4 Suppl 30):S8-14. PubMed ID: 14727452
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease.
    Liu X, Yang P, Wang C, Li F, Kijlstra A.
    Rheumatology (Oxford); 2011 Feb 28; 50(2):293-8. PubMed ID: 21059671
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.